Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)Dagmar Beier, Peter Hau, Martin Proescholdt et al.|Neuro-Oncology|2017Cited by 90
Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysisMaximilian Niyazi, Jürgen Debus, Frank Paulsen et al.|Radiotherapy and Oncology|2018Cited by 54
Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 TrialStefan Dietzsch, Martin Mynarek, Felix Placzek et al.|Advances in Radiation Oncology|2020Cited by 22
MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIALStefan Dietzsch, Martin Mynarek, Felix Placzek et al.|Neuro-Oncology|2020Cited by 0